Literature DB >> 31167914

Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome.

Maria Paola Pisano1, Nicole Grandi1, Marta Cadeddu1, Jonas Blomberg2, Enzo Tramontano3,4.   

Abstract

Eight percent of the human genome is composed of human endogenous retroviruses (HERVs), remnants of ancestral germ line infections by exogenous retroviruses, which have been vertically transmitted as Mendelian characters. The HML-6 group, a member of the class II betaretrovirus-like viruses, includes several proviral loci with an increased transcriptional activity in cancer and at least two elements that are known for retaining an intact open reading frame and for encoding small proteins such as ERVK3-1, which is expressed in various healthy tissues, and HERV-K-MEL, a small Env peptide expressed in samples of cutaneous and ocular melanoma but not in normal tissues.IMPORTANCE We reported the distribution and genetic composition of 66 HML-6 elements. We analyzed the phylogeny of the HML-6 sequences and identified two main clusters. We provided the first description of a Rec domain within the env sequence of 23 HML-6 elements. A Rec domain was also predicted within the ERVK3-1 transcript sequence, revealing its expression in various healthy tissues. Evidence about the context of insertion and colocalization of 19 HML-6 elements with functional human genes are also reported, including the sequence 16p11.2, whose 5' long terminal repeat overlapped the exon of one transcript variant of a cellular zinc finger upregulated and involved in hepatocellular carcinoma. The present work provides the first complete overview of the HML-6 elements in GRCh37(hg19), describing the structure, phylogeny, and genomic context of insertion of each locus. This information allows a better understanding of the genetics of one of the most expressed HERV groups in the human genome.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HERV; HERV-K-MEL; HML-6; RetroTector; bioinformatics; endogenous retrovirus

Mesh:

Year:  2019        PMID: 31167914      PMCID: PMC6675890          DOI: 10.1128/JVI.00110-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K.

Authors:  C Magin; R Löwer; J Löwer
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Constructing primate phylogenies from ancient retrovirus sequences.

Authors:  W E Johnson; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

3.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

4.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Differences in HERV-K LTR insertions in orthologous loci of humans and great apes.

Authors:  Y B Lebedev; O S Belonovitch; N V Zybrova; P P Khil; S G Kurdyukov; T V Vinogradova; G Hunsmann; E D Sverdlov
Journal:  Gene       Date:  2000-04-18       Impact factor: 3.688

6.  Characterization of human MMTV-like (HML) elements similar to a sequence that was highly expressed in a human breast cancer: further definition of the HML-6 group.

Authors:  H Yin; P Medstrand; A Kristofferson; U Dietrich; P Aman; J Blomberg
Journal:  Virology       Date:  1999-03-30       Impact factor: 3.616

7.  Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein.

Authors:  A Boese; M Sauter; U Galli; B Best; H Herbst; J Mayer; E Kremmer; K Roemer; N Mueller-Lantzsch
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

8.  Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database.

Authors:  M Tristem
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis.

Authors:  S Mi; X Lee; X Li; G M Veldman; H Finnerty; L Racie; E LaVallie; X Y Tang; P Edouard; S Howes; J C Keith; J M McCoy
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

10.  A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.

Authors:  Francesca Schiavetti; Joëlle Thonnard; Didier Colau; Thierry Boon; Pierre G Coulie
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

View more
  15 in total

1.  RNA-Seq Transcriptome Analysis Reveals Long Terminal Repeat Retrotransposon Modulation in Human Peripheral Blood Mononuclear Cells after In Vivo Lipopolysaccharide Injection.

Authors:  Maria Paola Pisano; Olivier Tabone; Maxime Bodinier; Nicole Grandi; Julien Textoris; François Mallet; Enzo Tramontano
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 2.  Retrotransposons as Drivers of Mammalian Brain Evolution.

Authors:  Roberto Ferrari; Nicole Grandi; Enzo Tramontano; Giorgio Dieci
Journal:  Life (Basel)       Date:  2021-04-22

3.  Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci.

Authors:  Nicole Grandi; Maria Paola Pisano; Sante Scognamiglio; Eleonora Pessiu; Enzo Tramontano
Journal:  Viruses       Date:  2020-04-23       Impact factor: 5.048

4.  Identification and characterization of ERV-W-like sequences in Platyrrhini species provides new insights into the evolutionary history of ERV-W in primates.

Authors:  Nicole Grandi; Maria Paola Pisano; Martina Demurtas; Jonas Blomberg; Gkikas Magiorkinis; Jens Mayer; Enzo Tramontano
Journal:  Mob DNA       Date:  2020-02-01

5.  HERV-K(HML7) Integrations in the Human Genome: Comprehensive Characterization and Comparative Analysis in Non-Human Primates.

Authors:  Nicole Grandi; Maria Paola Pisano; Eleonora Pessiu; Sante Scognamiglio; Enzo Tramontano
Journal:  Biology (Basel)       Date:  2021-05-14

6.  Human Endogenous Retroviruses (HERVs) and Mammalian Apparent LTRs Retrotransposons (MaLRs) Are Dynamically Modulated in Different Stages of Immunity.

Authors:  Maria Paola Pisano; Nicole Grandi; Enzo Tramontano
Journal:  Biology (Basel)       Date:  2021-05-05

Review 7.  High-Throughput Sequencing is a Crucial Tool to Investigate the Contribution of Human Endogenous Retroviruses (HERVs) to Human Biology and Development.

Authors:  Maria Paola Pisano; Nicole Grandi; Enzo Tramontano
Journal:  Viruses       Date:  2020-06-11       Impact factor: 5.048

8.  A human MMTV-like betaretrovirus linked to breast cancer has been present in humans at least since the copper age.

Authors:  Francesca Lessi; Nicole Grandi; Chiara Maria Mazzanti; Prospero Civita; Cristian Scatena; Paolo Aretini; Pasquale Bandiera; Antonio Fornaciari; Valentina Giuffra; Gino Fornaciari; Antonio Giuseppe Naccarato; Enzo Tramontano; Generoso Bevilacqua
Journal:  Aging (Albany NY)       Date:  2020-07-31       Impact factor: 5.682

Review 9.  Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target.

Authors:  Gislaine Curty; Jez L Marston; Miguel de Mulder Rougvie; Fabio E Leal; Douglas F Nixon; Marcelo A Soares
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.818

Review 10.  Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies.

Authors:  Ching-Hsuan Liu; Nicole Grandi; Lalitha Palanivelu; Enzo Tramontano; Liang-Tzung Lin
Journal:  Viruses       Date:  2020-08-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.